ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

3 Dawdling Stocks Facing Headwinds

ASLE Cover Image

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

Luckily for you, StockStory helps you navigate which companies are truly worth holding. Keeping that in mind, here are three low-volatility stocks to avoid and some better opportunities instead.

AerSale (ASLE)

Rolling One-Year Beta: 0.15

Providing a one-stop shop that integrates multiple services and product offerings, AerSale (NASDAQ: ASLE) delivers full-service support to mid-life commercial aircraft.

Why Are We Out on ASLE?

  1. Sales tumbled by 8.1% annually over the last two years, showing market trends are working against its favor during this cycle
  2. Negative free cash flow raises questions about the return timeline for its investments
  3. Diminishing returns on capital from an already low starting point show that neither management’s prior nor current bets are going as planned

AerSale’s stock price of $6.53 implies a valuation ratio of 13.4x forward price-to-earnings. Dive into our free research report to see why there are better opportunities than ASLE.

Brink's (BCO)

Rolling One-Year Beta: 0.69

Known for its iconic armored trucks that have been a fixture in American cities since 1859, Brink's (NYSE: BCO) provides secure transportation and management of cash and valuables for banks, retailers, and other businesses worldwide.

Why Do We Think Twice About BCO?

  1. Demand is forecasted to shrink as its estimated sales for the next 12 months are flat
  2. Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 1.3 percentage points
  3. Underwhelming 12.5% return on capital reflects management’s difficulties in finding profitable growth opportunities

At $91 per share, Brink's trades at 12.8x forward price-to-earnings. Read our free research report to see why you should think twice about including BCO in your portfolio.

Genpact (G)

Rolling One-Year Beta: 0.92

Originally spun off from General Electric in 2005 to provide business process services, Genpact (NYSE: G) is a global professional services firm that helps businesses transform their operations through digital technology, AI, and data analytics solutions.

Why Are We Hesitant About G?

  1. 4.4% annual revenue growth over the last two years was slower than its business services peers
  2. Weak constant currency growth over the past two years indicates challenges in maintaining its market share
  3. 2.5 percentage point decline in its free cash flow margin over the last five years reflects the company’s increased investments to defend its market position

Genpact is trading at $47.70 per share, or 13.8x forward price-to-earnings. To fully understand why you should be careful with G, check out our full research report (it’s free).

Stocks We Like More

Market indices reached historic highs following Donald Trump’s presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth.

While this has caused many investors to adopt a "fearful" wait-and-see approach, we’re leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 175% over the last five years.

Stocks that made our list in 2019 include now familiar names such as Nvidia (+2,183% between December 2019 and December 2024) as well as under-the-radar businesses like Sterling Infrastructure (+1,096% five-year return). Find your next big winner with StockStory today for free.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.